DJIA 17,113.54 61.81 0.36%
NASDAQ 4,456.02 31.31 0.71%
S&P 500 1,983.53 9.90 0.50%
market minute promo

145.87 -0.34 (-0.23%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

JAZZ $145.87 -0.23%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $146.67
Previous Close $146.21
Daily Range $145.48 - $149.37
52-Week Range $70.41 - $176.60
Market Cap $8.7B
P/E Ratio 119.84
Dividend (Yield) $0.00 (0.0%)
Volume 511,109
Average Daily Volume 838,760
Current FY EPS $7.39

Sector

Healthcare

Industry

Drugs

Jazz Pharmaceuticals, Inc. (JAZZ) Description

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Website: http://www.jazzpharma.com/

News & Commentary Rss Feed

Today’s Top Health Care Stories: Dr. Reddy’s Labs, Jazz, and Sanofi

Dr. Reddy’s Labs, Jazz, and Sanofi could all make health care headlines this morning. Here’s why.

Jazz Pharmaceuticals/Concert Pharmaceuticals Start Study - Analyst Blog

First Week of March 2015 Options Trading For Jazz Pharmaceuticals (JAZZ)

Your Best Wealth-Building Choice From Today's Top Market-Maker Price Range Forecasts

3 Stocks Moving The Health Care Sector Upward

Concert Pharmaceuticals' Shares Slip Despite Favorable FDA Meeting - Analyst Blog

Biotech Stock Roundup: Regado Plunges on Study Update, Jazz Gains on Product Acquisition Deal - Anal

Biotech Stock Roundup: Regado Plunges on Study Update, Jazz Gains on Product Acquisition Deal - Analyst Blog

Raptor Pharmaceuticals CEO to Retire, Appoints Successor - Analyst Blog

iShares U.S. Pharmaceuticals ETF Experiences Big Outflow

Jazz Pharmaceuticals to Buy Rights to Defibrotide, Shares Up - Analyst Blog

Jazz Pharmaceuticals to Buy Rights to Defibrotide, Shares Up - Analyst Blog

Jazz Pharmaceuticals Public Limited Company (JAZZ) in Focus: Stock Moves 6.9% Higher - Tale of the T

Jazz Pharmaceuticals Public Limited Company (JAZZ) in Focus: Stock Moves 6.9% Higher - Tale of the Tape

See More JAZZ News...

JAZZ's Top Competitors

JAZZ $145.87 (-0.23%)
Current stock: JAZZ
JNJ $102.47 (1.18%)
Current stock: JNJ
NVS $89.26 (0.76%)
Current stock: NVS
RHHBY $36.83 (0.30%)
Current stock: RHHBY